Identification of disease genes is a hot topic in biomedicine and genomics. However, it is a challenging problem because of the complexity of diseases. Inflammatory bowel disease (IBD) is an idiopathic disease caused by a dysregulated immune response to host intestinal microflora. It has been proven to be associated with the development of intestinal malignancies. Although the specific pathological characteristics and genetic background of IBD have been partially revealed, it is still an overdetermined disease and the blueprint of all genetic variants still needs to be improved. In this study, a novel computational method was built to identify genes related to IBD. Samples from two subtypes of IBD (ulcerative colitis and Crohn’s disease) an...
BACKGROUND: Genome-wide association studies (GWAS) have revealed many susceptibility loci for comple...
The advent of advanced molecular biological techniques in the last two decades has allowed the study...
Lifetime prevalence of inflammatory bowel disease (IBD) is reaching an alarming rate of >1/400 in in...
The patients of Inflammatory bowel disease (IBD) are increasing worldwide. IBD has the characteristi...
Abstract Background There are different and complicated associations between genes and diseases. Fin...
Abstract Background The rise of systems biology and availability of highly curated gene and molecula...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Background: The rise of systems biology and availability of highly curated gene and molecular inform...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Inflammatory bowel disease (IBD) consists of two main disease-subtypes, Crohn's disease (CD) and ulc...
Objective We aimed to identify differentially expressed genes (DEG) in patients with inflammatory bo...
In this study of inflammatory bowel diseases (IBD, i.e. Crohn's disease and ulcerative colitis), the...
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases characterized by recu...
BACKGROUND: Genome-wide association studies (GWAS) have revealed many susceptibility loci for comple...
BACKGROUND: Genome-wide association studies (GWAS) have revealed many susceptibility loci for comple...
The advent of advanced molecular biological techniques in the last two decades has allowed the study...
Lifetime prevalence of inflammatory bowel disease (IBD) is reaching an alarming rate of >1/400 in in...
The patients of Inflammatory bowel disease (IBD) are increasing worldwide. IBD has the characteristi...
Abstract Background There are different and complicated associations between genes and diseases. Fin...
Abstract Background The rise of systems biology and availability of highly curated gene and molecula...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Background: The rise of systems biology and availability of highly curated gene and molecular inform...
Inflammatory bowel disease encompasses a variety of heterogeneous chronic inflammatory diseases that...
Inflammatory bowel disease (IBD) consists of two main disease-subtypes, Crohn's disease (CD) and ulc...
Objective We aimed to identify differentially expressed genes (DEG) in patients with inflammatory bo...
In this study of inflammatory bowel diseases (IBD, i.e. Crohn's disease and ulcerative colitis), the...
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases characterized by recu...
BACKGROUND: Genome-wide association studies (GWAS) have revealed many susceptibility loci for comple...
BACKGROUND: Genome-wide association studies (GWAS) have revealed many susceptibility loci for comple...
The advent of advanced molecular biological techniques in the last two decades has allowed the study...
Lifetime prevalence of inflammatory bowel disease (IBD) is reaching an alarming rate of >1/400 in in...